Analystreport

Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on t

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors